JP2022546539A5 - - Google Patents
Info
- Publication number
- JP2022546539A5 JP2022546539A5 JP2022514014A JP2022514014A JP2022546539A5 JP 2022546539 A5 JP2022546539 A5 JP 2022546539A5 JP 2022514014 A JP2022514014 A JP 2022514014A JP 2022514014 A JP2022514014 A JP 2022514014A JP 2022546539 A5 JP2022546539 A5 JP 2022546539A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962894925P | 2019-09-02 | 2019-09-02 | |
| US62/894,925 | 2019-09-02 | ||
| US201962944233P | 2019-12-05 | 2019-12-05 | |
| US62/944,233 | 2019-12-05 | ||
| PCT/US2020/049061 WO2021046125A1 (en) | 2019-09-02 | 2020-09-02 | A new oncolytic virus platform to treat cancers with myxoma virus |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2022546539A JP2022546539A (ja) | 2022-11-04 |
| JPWO2021046125A5 JPWO2021046125A5 (https=) | 2023-09-08 |
| JP2022546539A5 true JP2022546539A5 (https=) | 2023-09-08 |
Family
ID=74681244
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022514014A Pending JP2022546539A (ja) | 2019-09-02 | 2020-09-02 | 粘液腫ウイルスを用いて癌を治療するための新しい腫瘍崩壊ウイルスプラットフォーム |
Country Status (11)
| Country | Link |
|---|---|
| US (3) | US11117934B2 (https=) |
| EP (1) | EP4025228A4 (https=) |
| JP (1) | JP2022546539A (https=) |
| KR (1) | KR20220112241A (https=) |
| CN (1) | CN114615988A (https=) |
| AU (1) | AU2020342510A1 (https=) |
| CA (1) | CA3152779A1 (https=) |
| IL (1) | IL291009A (https=) |
| MX (1) | MX2022002547A (https=) |
| TW (1) | TW202122411A (https=) |
| WO (1) | WO2021046125A1 (https=) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA3106202A1 (en) | 2018-07-13 | 2020-01-16 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of treating cancer with tnf expressing myxoma virus |
| WO2020051248A1 (en) * | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| EP3946373A4 (en) * | 2019-03-28 | 2023-01-11 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 FOR TREATING BLOOD CANCER |
| MX2022002547A (es) | 2019-09-02 | 2022-05-18 | Univ Arizona State | Una nueva plataforma de virus oncoliticos para tratar canceres con virus myxoma. |
| WO2022067038A1 (en) * | 2020-09-25 | 2022-03-31 | President And Fellows Of Harvard College | Immunotherapeutic virus for the treatment of cancer |
| CA3210350A1 (en) * | 2021-03-01 | 2022-09-09 | Leslie Lynne Sharp | Multi-armed myxoma virus |
Family Cites Families (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| ES2153284B1 (es) * | 1998-06-10 | 2001-09-01 | Fundacion Para El Estudio Y De | Nuevo virus recombinante de mixoma atenuado y su uso en la preparacion de vacunas mixtas contra la mixomatosis y la enfermedad hemorragica de los conejos. |
| KR100747646B1 (ko) | 2005-02-25 | 2007-08-08 | 연세대학교 산학협력단 | 데코린 유전자를 포함하는 유전자 전달 시스템 및 이를 포함하는 약제학적 항종양 조성물 |
| WO2007143545A2 (en) | 2006-06-01 | 2007-12-13 | Robarts Research Institute | Tnf signaling in myxoma virus treatments |
| EP2150618B1 (en) | 2007-05-04 | 2017-10-11 | University Health Network | Il-12 immunotherapy for cancer |
| FR2946536B1 (fr) * | 2009-06-11 | 2011-07-29 | Agronomique Inst Nat Rech | Utilisation d'une souche attenuee de myxoma virus comme oncolytique |
| WO2011156273A1 (en) * | 2010-06-06 | 2011-12-15 | Mount Sinai School Of Medicine | Recombinant rna viruses and uses thereof |
| CN114262690A (zh) * | 2011-04-15 | 2022-04-01 | 吉恩勒克斯公司 | 减毒的痘苗病毒的克隆毒株及其使用方法 |
| CN104039333B (zh) | 2011-06-09 | 2018-11-16 | 佛罗里达大学研究基金会有限公司 | 移植物抗宿主疾病的治疗或预防方法 |
| CN105829537B (zh) | 2013-11-28 | 2020-09-22 | 巴法里安诺迪克有限公司 | 用于使用痘病毒载体诱导增强的免疫应答的组合物和方法载体 |
| KR20160140075A (ko) | 2015-05-29 | 2016-12-07 | 코오롱생명과학 주식회사 | 폭스바이러스 유래 프로모터 및 이를 포함하는 벡터 |
| CN108025056B (zh) * | 2015-06-19 | 2022-01-14 | 新罗杰股份有限公司 | 用于病毒栓塞的组合物和方法 |
| WO2017123675A1 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells |
| WO2018027316A1 (en) * | 2016-08-09 | 2018-02-15 | Alkayyal Almohanad | Oncolytic rhabdovirus expressing il12 |
| WO2018156106A1 (en) | 2017-02-22 | 2018-08-30 | Ding Enyu | An mrna cancer vaccine encoding human gm-csf fused to multiple tandem epitopes |
| CA3106202A1 (en) | 2018-07-13 | 2020-01-16 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods of treating cancer with tnf expressing myxoma virus |
| KR20210042135A (ko) | 2018-08-08 | 2021-04-16 | 아리조나 보드 오브 리젠츠 온 비하프 오브 아리조나 스테이트 유니버시티 | 개선된 폭스바이러스 수율을 위한 방법 |
| AU2019321667A1 (en) | 2018-08-16 | 2021-03-04 | Musc Foundation For Research Development | Recombinant myxoma viruses and uses thereof |
| WO2020051248A1 (en) | 2018-09-05 | 2020-03-12 | Arizona Board Of Regents On Behalf Of Arizona State University | Oncolytic virus platform to treat hematological cancer |
| EP3946373A4 (en) | 2019-03-28 | 2023-01-11 | Arizona Board of Regents, a Body Corporate of the State of Arizona, acting for and on behalf of Arizona State University | ONCOLYTIC MYXOMA VIRUS EXPRESSING FAST P14 FOR TREATING BLOOD CANCER |
| US20220296660A1 (en) | 2019-09-02 | 2022-09-22 | Arizona Board Of Regents On Behalf Of Arizona State University | Methods and compositions for improving oncolytic virus infection for nonpermissive cancers |
| MX2022002547A (es) | 2019-09-02 | 2022-05-18 | Univ Arizona State | Una nueva plataforma de virus oncoliticos para tratar canceres con virus myxoma. |
| CA3210350A1 (en) | 2021-03-01 | 2022-09-09 | Leslie Lynne Sharp | Multi-armed myxoma virus |
-
2020
- 2020-09-02 MX MX2022002547A patent/MX2022002547A/es unknown
- 2020-09-02 US US17/010,711 patent/US11117934B2/en active Active
- 2020-09-02 WO PCT/US2020/049061 patent/WO2021046125A1/en not_active Ceased
- 2020-09-02 CA CA3152779A patent/CA3152779A1/en active Pending
- 2020-09-02 CN CN202080076788.8A patent/CN114615988A/zh active Pending
- 2020-09-02 JP JP2022514014A patent/JP2022546539A/ja active Pending
- 2020-09-02 TW TW109130086A patent/TW202122411A/zh unknown
- 2020-09-02 KR KR1020227010537A patent/KR20220112241A/ko not_active Ceased
- 2020-09-02 AU AU2020342510A patent/AU2020342510A1/en not_active Abandoned
- 2020-09-02 EP EP20861091.5A patent/EP4025228A4/en active Pending
-
2021
- 2021-06-24 US US17/357,624 patent/US20210324014A1/en not_active Abandoned
-
2022
- 2022-03-01 IL IL291009A patent/IL291009A/en unknown
- 2022-08-22 US US17/893,052 patent/US12331079B2/en active Active